65,437 trials
Hip Surgery Corrective
Primary: Change in Insulin Sensitivity (Percent) — -43; -38; -51 percent change of insulin sensitivity
Skin Aging
Primary: The First Visit Onset of Efficacy as Measured by Physician Assessment — 2.2 Number of Days
Constipation-predominant Irritable Bowel Syndrome
Primary: A Change in Length of Spread of Antegrade Contractions After Placebo.
Smoking · Smoking Cessation
Primary: A Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking — 208; 168 participants — p=0.008
Multiple Sclerosis
Primary: Change From Baseline in the Weekly 24-Hour Average Pain Scores at Week 6 (Acute Phase) — -1.83; -1.07 units on a scale — p=0.001
Cataract
Primary: Number of Participants With Summed Ocular Inflammation Score (SOIS) of Zero — 28; 20 Participants
Postpartum Hemorrhage
Primary: Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters. — -20.8; -41.7; -53.5; -96.0 milliliters — p=<0.05
Congenital Heart Disease · Disorder of Fetus or Newborn
Primary: Primary Endpoint: Number of Participants With Low Cardiac Output Syndrome (LCOS) or Death at 36 Hours From Admission to the Intensive Care Unit (ICU) After Surgery…
Labor Pain
Primary: Total Bupivicaine in Milligrams Administered Per Hour of Labor for Analgesia. — 11.3; 11.1; 10.3 mg bupivacaine per hour — p=>0.05
Eyelash Hypotrichosis
Primary: Change From Baseline in Eyelash Length at Month 3 — 5.65; 5.68; 5.95; 0.74 millimeters (mm)
Cataract Surgery
Primary: Number of Participants With Summed Ocular Inflammation Score (SOIS) of Zero — 157; 164 Participant
Asthma
Primary: Rate of Asthma Exacerbations Over the 24 Week Treatment Period — 0.205; 0.258 exacerbations per 24 patient-week period
Blood Loss, Surgical
Primary: Number or Participants With Antirecombinant Thrombin (rThrombin) Product Antibody at Baseline and Day 29 — 0; 0 Participants
Blood Loss, Surgical
Primary: Number of Participants With Death, Serious Adverse Events, Treatment-related Adverse Events (AE), AEs Leading to Discontinuation, and AEs of Hypersensitivity — 0; 1; 0…
Eosinophilic Esophagitis
Primary: Number of Participants With Complete Response to Dysphagia — 9; 6 participants — p=0.74